Latest News
-
Emory’s antibody study sheds light on COVID-19 immunity
May 26, 2020Woodruff Health Sciences Center | May 20, 2020
ATLANTA – New research from Emory University indicates that nearly all people hospitalized with COVID-19 develop virus-neutralizing antibodies within six days of testing positive. The findings will be key in helping researchers understand protective immunity against SARS-CoV-2 and in informing vaccine development.
-
Center for Pediatric Cellular Therapies: Clinical Trial Launch Grants 2020
May 26, 2020The Center for Pediatric Cellular Therapies (CPCT) is accepting Late Stage Preclinical/IND Enabling Research and Clinical Trial Launch Grant applications. Applications are due July 1, 2020 by 6:00 PM.
-
Special COVID-19 BiRD Edition!
May 22, 2020We’ve curated dozens of COVID-19 related research funding announcements to bring you this special COVID-19 Bringing in the Research Dollars edition to highlight some of the most relevant and timely Funding Opportunity Announcements (first section), Notices of Special Interest (second section), and a forecasted opportunity to be on the lookout for (third section). Please remember that our Pediatric Cores are available to support essential research activities and for Emory based grants, the Emory Facilities and Resources boilerplate tool provides researchers easy access to the most updated and relevant information to include in grant submissions.
-
Trends in outpatient procedural sedation from 2007–2018
May 19, 2020Emory Department of Pediatrics faculty Pradip P. Kamat, Courtney E. McCracken, Harold K. Simon and other researchers looked into trends in outpatient procedural sedation from 2007 to 2018. Pediatric subspecialists routinely provide procedural sedation outside the operating room. …
-
13-year-old Patient Receives First-Ever Dose of New Peanut Allergy Treatment
May 19, 2020On Friday, March 13, in a groundbreaking milestone moment in the food allergy world, Children’s Healthcare of Atlanta’s Dr. Brian Vickery administered the first-ever dose of a new FDA-approved peanut allergy oral immunotherapy treatment for pediatric patients.…
-
Emory, Lilly, NIAID join clinical trial to show efficacy of remdesivir & baricitinib against COVID
May 11, 2020Emory, Lilly, NIAID join academic centers in clinical trial to demonstrate efficacy of remdesivir and baricitinib against COVID-19
-
CCIV Special Coronavirus Pilot Award
May 04, 2020Congratulations to Mehul Suthar, PhD and Anne Piantadosi, MD, PhD, whose research project titled “Genomics and Pathogenesis of SARS-CoV-2” was selected for funding as the CCIV Special Coronavirus Pilot Award
-
Emory University helps test the nation’s first potential COVID-19 vaccine and possible treatments
May 04, 2020From Atlanta Magazine: Emory University helps test the nation’s first potential COVID-19 vaccine and possible treatments The race against COVID-19 BY MICHELE COHEN MARILL - MAY 1, 2020 Evan Anderson, an infectious-disease doctor, heads to his post on the…